Earnings beat estimates by .07/sh net income (vs. loss of .01 est.) and $3.6 mil on $22.1 mil in revenue
Street estimates were looking for a loss of .06/share and we earned .01. Revenue estimate was $18.47 mil and we did $22.1 mil, beating by $3.6 mil. All clinicals still on schedule. Only had a $1.3 mil burn for the quarter and still have $137 mil in cash or equivs. GREAT, WAY TO GO LONGS.
Now for the future, can't wait to hear the conference call. Don't forget to listen.